The emerging strains of Shigella dysenteriae type 2 in Bangladesh are clonal

Epidemiology and Infection

Volumn 134, Issue 6, 2006, Pages 1249-1256

  Talukder, Kaisar A ^a,c   Khajanchi, B K ^a   Islam, M A ^a   Dutta, D K ^a   Islam, Z ^a   Khan, S I ^b   Nair, G B ^a   Sack, D A ^a  

^a ICDDR B Centre for Health and Population Research   (Bangladesh)

^b UNIVERSITY OF DHAKA   (Bangladesh)

^c ICDDRB Laboratory Sciences Division   (Bangladesh)

Author keywords

[No Author keywords available]

Indexed keywords

ARABINOSE; CIPROFLOXACIN; CONGO RED; MECILLINAM; NALIDIXIC ACID;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; BANGLADESH; CLINICAL FEATURE; CLONAL VARIATION; CONTROLLED STUDY; DIARRHEA; FERMENTATION TECHNIQUE; GENE IDENTIFICATION; HUMAN; NONHUMAN; PLASMID; POLYMERASE CHAIN REACTION; PULSED FIELD GEL ELECTROPHORESIS; RIBOTYPING; SEROTYPE; SHIGELLA DYSENTERIAE; SHIGELLOSIS;

BANGLADESH; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; DYSENTERY, BACILLARY; ELECTROPHORESIS, GEL, PULSED-FIELD; GENES, BACTERIAL; GENOTYPE; HUMANS; PHENOTYPE; PLASMIDS; RIBOTYPING; SHIGELLA FLEXNERI;

EID: 33750311753     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268806006029     Document Type: Article

References (34)

1. Murray CJ, Lopez AD. Mortality by cause for eight reasons of the world: global burden of disease study. Lancet 1997; 349: 1269-1276.
2. Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global burden of disease study. Lancet 1997; 349: 1436-1442.
3. Melito PL, et al. A novel Shigella dysenteriae serovar isolated in Canada. Journal of Clinical Microbiology 2005; 43: 740-744.
4. Kotloff KL, et al. Global burden of Shigella infections: Implications for vaccine development and implementation of control strategies. Bulletin of the World Health Organization 1999; 77: 651-666.
5. Ashkenazi S, et al. Growing antimicrobial resistance of Shigella isolates. Journal of Antimicrobial Chemotherapy 2003; 512: 427-429.
6. Dutta S, et al. Shifting serotypes, plasmid profile analysis and antimicrobial resistance pattern of shigellae strains isolated from Kolkata, India during 1995-2000. Epidemiology and Infection 2002; 129: 235-243.
7. Rahman M, et al. Extended-spectrum beta-lactamase-mediated third-generation cephalosporin resistance in Shigella isolates in Bangladesh. Journal of Antimicrobial Chemotherapy 2004; 54: 846-847.
8. Talukder KA, et al. Genetic relatedness of ciprofloxacin-resistant Shigella dysenteride type 1 strains isolated in south Asia. Journal of Antimicrobial Chemotherapy 2004; 54: 730-734.
9. WHO. Antimicrobial resistance in shigellosis, cholera and campylobacteriosis. Document WHO/CDS/CSR/DRS/8. Geneva: World Health Organization, 2001.
10. Fontaine A, Arondel J, Sansonetti PJ. Construction and evaluation of five attenuated vaccine strains of Shigella flexneri and Shigella dysenteriae 1. Research in Microbiology 1990; 141: 907-912.
11. Formal SB, Baker EE. Quantitative studies of cross-reactions between Shigella flexneri types 1a, 1b, and 3. Journal of Immunology 1953; 70: 260-266.
12. Talukder KA, et al. Altering trends in the dominance of Shigella flexneri serotypes and emergence of serologically atypical S. flexneri strains in Dhaka, Bangladesh. Journal of Clinical Microbiology 2001; 39: 3757-3759.
13. Talukder KA, et al. Temporal shifts in the dominance of serotypes of Shigella dysenteriae from 1999 to 2002 in Dhaka, Bangladesh. Journal of Clinical Microbiology 2003; 41: 5053-5058.
14. Talukder KA, et al. Phenotypic and genotypic characterization of serologically atypical strains of Shigella flexneri type 4 isolated in Dhaka, Bangladesh. Journal of Clinical Microbiology 2002; 40: 2490-2497.
15. Talukder KA, et al, Phenotypic and genotypic characterization of provisional serotype Shigella flexneri 1c and clonal relationships with 1a and 1b strains isolated in Bangladesh. Journal of Clinical Microbiology 2003; 41: 110-117.
16. WHO. Manual for laboratory investigations of acute enteric infections. Document WHO/CDD/93.3 Geneva: World Health Organization, 1987.
17. Sasakawa C, et al, Molecular alteration of the 140-megadalton plasmid associated with loss of virulence and Congo red binding activity in Shigella flexneri. Infection and Immunity 1986; 51: 470-475.
18. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing; approved standard, 14th edn; document M100-S14. Villanova, PA, 2004.
19. Vargas M, et al. Prevalence of Shigella enterotoxin 1 and 2 among Shigella strains isolated from patients with Traveler's diarrhea. Journal of Clinical Microbiology 1999; 37: 3608-3611.
20. Haider K, et al. Electropherotyping of plasmid DNA of different serotypes of Shigella flexneri isolated in Bangladesh. Epidemiology and Infection 1989; 102: 421-428.
21. Munshi MH, et al. Plasmid mediated resistance to nalidixic acid in Shigella dysenteriae type 1. Lancet 1987; 2: 419-421.
22. Talukder KA, Dutta DK, Albert MJ. Evaluation of pulsed-field gel electrophoresis for typing of Shigella dysenteriae type 1. Journal of Medical Microbiology 1999; 48: 781-784.
23. Albert MJ, et al. Phenotypic and genotypic changes in Vibrio cholerae O139 Bengal. Journal of Clinical Microbiology 1997; 35: 2588-2592.
24. Okada N, et al. Construction of a physical map of the chromosome of Shigella flexneri 2a and the direct assignment of nine virulence-associated loci identified by Tn5 insertions. Molecular Microbiology 1991; 5: 2171-2780.
25. Tenover FC, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: Criteria for bacterial strain typing. Journal of Clinical Microbiology 1995; 33: 2233-2239.
26. Talukder KA, et al. An unusual cluster of dysentery due to Shigella dysenteriae type 4 in Dhaka, Bangladesh. Journal of Medical Microbiology 2005; 54: 511-513.
27. Ewing WH. The genus Shigella. In: Ewing WH, ed. Identification of Enterobacteriaceae. New York: Elsevier Science Publishing Co. Inc., 1986, pp. 135-172.
28. Sansonetti PJ, Kopecko DJ, Formal SB. Involvement of a plasmid in the invasive ability. of Shigella flexneri. Infection and Immunity 1982; 135: 852-860.
29. Sansonetti PJ, et al. Alterations in the pathogenicity of Escherichia coli K-12 after transfer of plasmid and chromosomal genes from Shigella flexneri. Infection and Immunity 1983; 39: 1392-1402.
30. Maurelli AT, Blackmon B, Curtiss R. Loss of pigmentation in Shigella flexneri is correlated with loss of virulence and virulence associated plasmid. Infection and Immunity 1984; 43: 397-401.
31. Watanabe H, Nakamura A. Large plasmid associated with virulence in Shigella species have a common function necessary for epithelial cell penetration. Infection and Immunity 1985; 48: 260-262.
32. Venkatesan MM, Buysse JM, Kopecko DJ. Use of Shigella flexneri ipaC and ipaH gene sequences for the general identification of Shigella spp. and entero-invasive Escherichia coli. Journal of Clinical Microbiology 1989; 27: 2687-2691.
33. Surdeanu M, et al. Differentiation of Shigella strains by plasmid profile analysis, serotyping and phage typing. Roumanian Archives of Microbiology and Immunology 2000; 59: 103-117.
34. Haider K, et al. Plasmid characterization of Shigella species isolated from children with shigellosis and asymptomatics excretors. Journal of Antimicrobial Chemotherapy 1985; 16: 691-698.